This page contains affiliate links. We may earn a commission at no cost to you. How we earn
GLP-1Doc
When the Answer Is No

GLP-1 Denied: How to Appeal Your Insurance Decision

Updated May 17, 2026 · Medically reviewed content

📋 Key Takeaway

About 30–50% of well-documented GLP-1 insurance appeals succeed. A denial is not the final answer. The most common reason for denial is incomplete documentation, not medical ineligibility — meaning many denials are fixable.

A denial is the beginning, not the end

Getting a prior authorization denial for GLP-1 medication is frustrating — but it's also common, and frequently reversible. Data from multiple sources suggests that 30–50% of well-documented appeals for GLP-1 medications succeed. The key word is "well-documented." Most initial denials stem from incomplete paperwork, not from genuine medical ineligibility.

Step 1: Understand why you were denied

Request the specific reason for denial in writing. Common denial reasons include insufficient documentation of BMI and weight-related comorbidities, no evidence of prior weight management attempts, medication is excluded from your plan's formulary entirely, your plan requires trying a different medication first (step therapy), or missing lab work or clinical documentation.

Each of these has a different appeal strategy. A formulary exclusion (the plan doesn't cover weight loss medications at all) is the hardest to overcome — in many cases, there's no appeal pathway because the medication category itself is excluded, not your individual claim.

Step 2: Gather your documentation

Appeal Documentation Checklist

BMI documentation: Measured BMI at the time of initiating treatment, with date and provider

Comorbidity evidence: Diagnoses of hypertension, type 2 diabetes, dyslipidemia, sleep apnea, or cardiovascular disease with supporting lab/test results

Prior weight loss attempts: Documented participation in diet, exercise, or behavioral programs — ideally 6+ months of history

Lab results: HbA1c, lipid panel, metabolic panel — showing metabolic dysfunction

Clinical guidelines: References to AACE, Endocrine Society, or ADA guidelines supporting GLP-1 use for your conditions

Letter of medical necessity: A detailed letter from your prescribing provider explaining why this specific medication is medically necessary for you

Step 3: The letter of medical necessity

This is your most powerful tool. Your provider writes this letter, but you can (and should) help by providing the documentation they need. A strong letter includes your clinical diagnosis with ICD-10 codes, specific BMI and metabolic markers, a summary of prior weight management attempts and their outcomes, an explanation of why this specific GLP-1 medication is medically necessary (citing clinical trial evidence), references to published clinical guidelines that support the prescription, and a statement of the health consequences of untreated obesity for your specific situation.

Step 4: File the appeal within the deadline

Appeal deadlines vary by plan but are typically 30–180 days from the denial notice. Missing the deadline can force you to restart the entire prior authorization process. Mark the deadline on your calendar the day you receive the denial. Most plans allow two levels of internal appeal (the second reviewed by a different person than the first), plus the right to an external review by an independent third party if both internal appeals fail.

Step 5: If the appeal fails — external review and other options

If your internal appeals are denied, you can request an external review through your state's insurance department. External reviewers are independent of your insurer and evaluate your case against accepted medical standards. You can also file a complaint with your state insurance commissioner, especially if you believe the denial violates state obesity treatment mandates (several states now require coverage of obesity medications).

While appealing, you don't have to wait. Many patients begin treatment through cash-pay telehealth providers (compounded GLP-1 at $149–$299/mo) while their insurance appeal processes. If the appeal eventually succeeds, you can transition to brand-name medication under insurance coverage.

Document your baseline weight

One critical detail that trips up many patients later: document your baseline weight at the very start of treatment. Insurance renewals often require evidence of at least 5% weight loss from baseline. If you can't prove your starting weight, renewal can be denied even if you're clearly responding to the medication. Get it on record — clinic visit, telehealth screenshot, whatever works — and save it.

🩺 Explore Your Options While Appealing

Compounded medications are not FDA-approved. Consult a licensed provider to determine if treatment is appropriate for you.

Brand-Name

Sesame Care

From $59/mo program

Medication from $149/mo

FDA-approved brand-name GLP-1 medications only — Wegovy, Zepbound, Foundayo. Insurance support available.

See Plans
Paid link

Found Health

From $99/mo program

$100 off first order

250K+ patients. 15+ medication options including brand-name Wegovy ($499/mo) and Zepbound (from $349). Insurance navigation support.

Get $100 Off
Paid link
Editor's Pick

Embody

$149 first month

$299/mo refills

Compounded semaglutide with metabolic report, 1:1 guidance, and personalized plan.

Start for $149
Paid link

Related Guides

GLP-1 Insurance Coverage Guide 2026 →Medicare GLP-1 Bridge Program →

Sources & References

1. U.S. News, "Navigating Insurance Coverage for GLP-1 Medications." March 2026.

2. CMS, External Review Process guidance. 2025.

3. AACE/Endocrine Society guidelines for obesity pharmacotherapy. 2023.

4. Telehealth Ally, "GLP-1 Insurance Coverage Guide." 2026.